EMA401

· Spinifex Pharmaceuticals Pty Ltd

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EMA401, covering 2015-08-26 to 2020-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN) [Phase 2]